UTHR - United Therapeutics Q4 2022 Earnings Preview
- United Therapeutics ( NASDAQ: UTHR ) is scheduled to announce Q4 earnings results on Wednesday, February 22nd, before market open.
- The consensus EPS Estimate is $5.21 (+48.4% Y/Y) and the consensus Revenue Estimate is $519.2M (+25.0% Y/Y).
- Over the last 2 years, UTHR has beaten EPS estimates 75% of the time and has beaten revenue estimates 88% of the time.
For further details see:
United Therapeutics Q4 2022 Earnings Preview